Previous close | 0.0500 |
Open | 0.0500 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 22.50 |
Expiry date | 2024-08-16 |
Day's range | 0.0500 - 0.0500 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Key Insights BioLife Solutions' estimated fair value is US$24.08 based on 2 Stage Free Cash Flow to Equity BioLife...
Todd Berard, Chief Marketing Officer of BioLife Solutions Inc (NASDAQ:BLFS), executed a sale of 10,000 shares of the company on June 14, 2024.
BioLife's (BLFS) latest product, CryoCase, is compatible with various downstream processing systems, including its own Signata CT-5.